Skip to main content
Log in

L-Lysine Dehydrogenase Deficiency in a Patient with Congenital Lysine Intolerance

  • Letter
  • Published:

From Nature

View current issue Submit your manuscript

Abstract

RECENTLY, a new metabolic defect, which was believed to arise from congenital lysine intolerance, was described in a 3-month-old baby girl1. An enzymatic impairment in the pathway for the degradation of lysine seemed the most probable explanation of the main finding, that is, high plasma lysine levels. Because the enzymes responsible for the metabolism of lysine in human beings had not previously been investigated, efforts were made to find an enzyme system capable of degrading lysine. This report presents evidence for the existence of a hitherto unknown enzyme, L-lysine: nicotinamide-adenine dinucleotide (NAD) - oxidoreductase (deaminating) (trivial name: L-lysine dehydrogenase) in human liver homogenates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Colombo, J. P., Richterich, R., Donath, A., Spahr, A., and Rossie, E., Lancet, 1014 (1964).

  2. Meister, A., The Biochemistry of Amino Acids (Academic Press, Inc., New York, 1957).

    Google Scholar 

  3. Büngi, W., and Richterich, R., Helv. Physiol. Acta, 23, 183 (1965).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BÜRGI, W., RICHTERICH, R. & COLOMBO, J. L-Lysine Dehydrogenase Deficiency in a Patient with Congenital Lysine Intolerance. Nature 211, 854–855 (1966). https://doi.org/10.1038/211854a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/211854a0

  • Springer Nature Limited

This article is cited by

Navigation